Skip to main content
     
         www.Google.com  


CSIR launches Ayurvedic anti-diabetic drug BGR-34

    1. Developed jointly by NBRI & CIMAP, research units of CSIR

    2. Scientifically validated for its efficacy and safety

    3. Price only Rs 5/- per Tablet. 

Council for Scientific and Industrial Research (CSIR), today launched BGR-34 - country’s first anti-diabetic ayurvedic drug with DPP4 inhibitory Activity. BGR-34, designed for type 2 Diabetes mellitus has been scientifically validated for its efficacy and safety. BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR, Govt. of India situated at Lucknow. Passing its larger benefits to people, BGR-34 has been economically priced at Rs. 5 per tablet as compared to latest DPP4 inhibitors globally. BGR-34 is now available on all major chemist counters of Kerala.
Speaking on the occasion Dr.A.K.S. Rawat, Sr. PrincipalScientist, CSIR-NBRI said “6 crore of the adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet. We are sure that eminent medical professionals will recommend it to their patients suffering from type 2 Diabetes mellitus for quicker and consistent response. CSIR's premier research institutions have developed and established the efficacy of BGR-34. The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs."
The scientists of NBRI and CIMAP, joined hands in developing an effective, safe, patient friendly solution towards management of type 2 Diabetes mellitus. They had in-depth study of over 500 renowned ancientherbs and finally identified the 6 best herbs listed in Ayurvedic ancient texts for various ailments and indications namely Daruharidra (Berberisaristata), Giloy (Tinosporacordifolia), Vijaysar (Pterocarpus marsupium), Gudmar (GymnemaSylvestre), Majeeth (Rubiacordifoila) and Methika (Trigonellafoenum-graecum) to be combined in different fractions &quantity and processed meticulously to develop a marvelous anti-diabetic formulation. The herbs were further subjected to optimization studies to establish the right proportion.

Dr Ch V Rao, Principal Scientist CSIR-NBRI,said, "BGR-34 is a unique product that manages the lives of human suffering diabetics. One of the critical ingredients inhibits DPP-4 and enhances insulin secretion. The product passed several battery of tests and showed hypoglycemic activity in experimental subjects."

Pre-clinical studies of this antidiabetic formulation revealed significant reduction in high blood sugar level in diabetes induced experimental subjects, with the activity being comparable with the reference standard anti-diabetic allopathic drug. Besides, the drug was found to improve LFTs,KFT’s and lipid profile significantly.It also provided the much needed pronounced antioxidant protective activity. No untoward effects were observed during the course of study. Clinical studies with BGR-34 have also revealed significant anti-diabetic activities with no untoward effects observed.


For the purpose ofquality commercial production and extended distribution, Aimil Pharmaceuticals (I) Ltd, the organization well known for its innovative, quality Herbal / Ayurvedic products,has been transferred the rights & technical knowhow to produce and market it for medical use. The company is manufacturing BGR-34 at its state of the art manufacturing units, which are well equipped with latest technology for manufacturing quality medicines with astringent most quality control measures.
Mr. K. K. Sharma, Managing director of AIMIL Pharmaceuticals, said "We are happy to be partner with institutes of such repute for passing on its benefits to the people. We have  decided to launch this marvellous anti-diabetic product in the brand name BGR-34, standing for Blood Glucose Regulator with 34 identified active phyto-constitutents from herbal resources. With a strong marketing distribution network spread all over the country, Aimil is strongly committed to carry forward the marvellous benefits of this novel research to the suffering masses all throughout the country and abroad."
Aimil Pharmaceuticals, already had one successful technological collaboration with DRDO (Defence Research and Development Organization, Govt. of India) yet another premier research institute in the country, for effective and safe treatment of leukoderma, still considered to be a big challenge to address. The product for leucoderma was successfully launched in the market in the name Lukoskin, bringing smiles for the patient suffering from the social stigma, leucoderma. In appreciation to its research work and commitment to develop high quality innovative drugs, Aimil Pharmaceuticals has been bestowed with 3 national awards from Govt. of India for manufacturing herbal medicines of outstanding quality and also for research and development activities.


For more details please contact

Vishal Mishra

Kaivalya Communication

 8756000222



 






Comments

Post a Comment

Popular posts from this blog

International Health Service Launched by Mera Doctor

24x7 Free Helpline: 022-61336155 International Health Service Launched, Making Healthcare in U.P. Easier and Cheaper Lucknow, April, 5 2013 – MeraDoctor, India’s leading independent provider of medical advice by phone, today announced the launch of the country’s first  health protection service , including 24-hour medical guidance from MBBS doctors plus insurance and medical discounts. The service has been specially adapted for the Indian market from similar offerings in the US, UK and Canada. “Every day in Lucknow and across U.P., lakhs and lakhs of people struggle to get reliable medical advice for minor ailments. And they struggle to pay for treatments when these ailments become serious. Our new health protection service makes their lives easier by giving them 24 x 7 advice from MBBS doctors by phone on 022-61336155, plus discounts on their medical expenses and insurance against accidents and hospitalisation,” said Dr Ajay Nair, MeraDoctor’s co-founder. The ser...
1 comment
Read more

Functions of Public Relation

Functions of Public Relation Public Relations refers to be the bridge for building the image and maintaining the relations between the organisation and the masses. Press Release: Press releases are considered to be an important element for the PR agency. Press Release helps in settings the story and gets the good media coverage. A well-written press release is still in demand and requires a short message with the hand full of details. When your agency has news or any upcoming events to share, there is value in creating a release as it will bring you good coverage. But, before you start writing the press release, one should be aware of the pattern used for releases.  News Conference:  Holding a press conference without a hitch  is definitely not an easy task. Right amount of considerable time is required to do this. The major benefit of press conference is that you don’t have to repeat the same thing to different reporters again and ag...
Post a Comment
Read more
KEI INDUSTRIES celebrates Golden Jubilee Year in Lucknow Accelerating UP Retail business to Another Level   ·          Targeting Retail Business Expansion-> INR 250 Cr (Wire: 100 Cr + Cable: 150Cr) by 2020-21 ·          Targeting Dealer Network Expansion-> 225 Direct dealers & 1500 Retail Counters by 2020-21   The country’s one of the leading wire and cable manufacturer KEI INDUSTRIES LTD announced the celebration of its ‘Golden Jubilee Year’ in Lucknow by expanding its direct and indirect dealers network in the state. On the occasion, the Chairman cum Managing Director of the company announced the doubling of the network size in three years.  At the Lucknow meet, the top dealers and distributors discussed KEI’s journey of 50 years and various business prospects with the CMD and senior management of the company. Commenting on the occasion, Mr Anil Gupta,...
Post a Comment
Read more